Search by Drug Name or NDC

    NDC 61314-0320-01 Olopatadine Hydrochloride 665 ug/100uL Details

    Olopatadine Hydrochloride 665 ug/100uL

    Olopatadine Hydrochloride is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is OLOPATADINE HYDROCHLORIDE.

    Product Information

    NDC 61314-0320
    Product ID 61314-320_0f71b717-d3f6-4b3b-87d2-60327ea5831f
    Associated GPIs 42401060102020
    GCN Sequence Number 063890
    GCN Sequence Number Description olopatadine HCl SPRAY/PUMP 0.6 % NASAL
    HIC3 Q7E
    HIC3 Description NASAL ANTIHISTAMINE
    GCN 99602
    HICL Sequence Number 012815
    HICL Sequence Number Description OLOPATADINE HCL
    Brand/Generic Generic
    Proprietary Name Olopatadine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name olopatadine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SPRAY, METERED
    Route NASAL
    Active Ingredient Strength 665
    Active Ingredient Units ug/100uL
    Substance Name OLOPATADINE HYDROCHLORIDE
    Labeler Name Sandoz Inc
    Pharmaceutical Class Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021861
    Listing Certified Through 2024-12-31

    Package

    NDC 61314-0320-01 (61314032001)

    NDC Package Code 61314-320-01
    Billing NDC 61314032001
    Package 1 BOTTLE in 1 CARTON (61314-320-01) / 30500 uL in 1 BOTTLE
    Marketing Start Date 2015-04-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.10226
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description OLOPATADINE 665 MCG NASAL SPRY
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis